¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"toxic agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • dehydrating agent
    Å»¼öÁ¦
  • denaturizing agent
    º¯¼ºÁ¦
  • depolarizing agent
    Å»ºÐ±ØÁ¦
  • diagnostic agent
    Áø´Ü¾à
  • diluting agent
    Èñ¼®Á¦
  • etiologic agent
    ¿øÀÎü, º´ÀÎü
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØ¹°Áú
  • ganglionic blocking agent
    ½Å°æÀýÂ÷´ÜÁ¦
  • germicidal agent
    »ì±ÕÁ¦
  • health care agent
    °Ç°­°ü¸®¿ä¿ø, °Ç°­°ü¸®±â±¸
  • induction agent
    À¯µµ¹°Áú
  • infectious agent
    °¨¿°Ã¼, °¨¿°¿ø
  • ischemia-inducing agent
    ÇãÇæÀ¯µµÁ¦
  • lipotropic agent
    Ä£Áö¹æ¾à
  • masking agent
    Â÷ÆóÁ¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • radioprotective agent
    ¹æ»ç¼±¹æÈ£Á¦
  • radiosensitive agent
    ¹æ»ç¼±°¨ÀÛ¹°Áú, -¹Î°¨Á¦
  • receptor blocking agent
    ¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
  • reducing agent
    ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • toxic retinopathy
    Áßµ¶¸Á¸·º´Áõ
  • toxic shock syndrome
    µ¶¼Ò¼ï ÁõÈıº (Æ÷µµ±¸±Õ)
  • toxic shock syndrome
    µ¶¼º ¼ïÁõÈıº
  • toxic shock syndrome toxin-1
    µ¶¼Ò¼ï ÁõÈıº À¯¹ßµ¶¼Ò-1
  • toxic substance
    À¯µ¶¼ººÐ(êóÔ¸à÷ÝÂ), µ¶¹°(Ô¸Úª), µ¶¼º¹°Áú.
  • toxic tolerance
    µ¶¹°³»¼º(Ô¸ÚªÒ±àõ).
  • toxic unit
    Áßµ¶´ÜÀ§(ñéÔ¸Ó¤êÈ), µ¶¼Ò´ÜÀ§(Ô¸áÈÓ¤êÈ).
  • addition agent
    ÷°¡Á¦(ôÕÊ¥ð¥).
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°(¼º) ºÀ¼â<Â÷´Ü>¾à.
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°¾à.
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°¼º¾à¹°
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°(¼º)¾à.
  • agent
    ¾à¹°<Á¦>, ÀÛ¿ë¹°Áú(íÂéÄÚªòõ), º´ÀÎ(Ü»ì×).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
MSAA multiple sclerosis-associated agent
narco narcotic, narcotic addict, drug enforcement agent
NMB neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ...
NMBA neuromuscular blocking agent
NSAIA nonsteroidal anti-inflammatory agent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 6
DTG diffuse toxic goiter
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • potassium-sparing agent

    potency

    ÀáÀç´É, ÀáÀç·Â, È¿·Â, ¿ª°¡
  • protective agent
    º¸È£ ¾à, ÇÇÆ÷ ¾à
  • psychedelic agent
    ȯ°¢Á¦
  • radioopaque agent
    ¹æ»ç¼± ºÒÅõ°ú¼º Á¦Àç, ¹æ»ç¼± ºñÅõ°ú¼º Á¦Àç
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • radioprotective agent
    ¹æ»ç¼± ¹æ¾îÁ¦
    ¹°¸®Àû È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • radiosensitive agent
    ¹æ»ç¼±Áõ Á¦¾à
    X¼± ¶Ç´Â ±âŸ ´Ù¸¥ ¹æ»ç¼± ¿¡³ÊÁö¿¡ ´ëÇÑ °¨¼ö¼ºÀ» Áõ°­½ÃŰ´Â ¾à¹°.
  • receptor blocking agent
    ¼ö¿ëü Â÷´ÜÁ¦
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø ¹°Áú
  • sclerosing agent
    °æÈ­ ¾à, °æÈ­Á¦
  • silane coupling agent
    ½Ç¶õÄ¿ÇÁ¸µÁ¦
    ±âÀç¿Í ÇÊ·¯ÀÇ »çÀÌ¿¡ À־ ¾çÀÚ¸¦ È­ÇÐÀûÀ¸·Î °áÇÕÇϰí Á¢Âø È¿°ú¸¦ ³ôÀ̴µ¥ »ç¿ëµÇ´Â ½Ç¶õÁ¦.
  • skin test agent
    ÇǺΠ¹ÝÀÀ ¾à
  • spermicidal agent
    »ìÁ¤Á¦
  • sympathetic blocking agent
    ±³°¨½Å°æ ºÀ¼âÁ¦, ±³°¨½Å°æ Â÷´ÜÁ¦
  • sympatholytic agent
    ±³°¨½Å°æ ¾ïÁ¦Á¦
    ±³°¨½Å°æÀÇ ÀÛ¿ëÀ» ¾ïÁ¦ÇÏ´Â ¾à. ±³°¨½Å°æ ÈïºÐÁ¦¿Í ±æÇ×ÇÑ´Ù. ÀÌ ¾àÀº ´ÙÀ½°ú °°Àº Á¾·ùÀÇ °ÍÀÌ Æ÷ÇԵǴµ¥, ¨ç Ä«Å×ÄݾƹÎ
  • sympathomimetic agent
    ±³°¨½Å°æ ÈïºÐÁ¦
    ±³°¨½Å°æÀÌ ÈïºÐÇßÀ» ¶§¿Í °°Àº ÀÛ¿ëÀ» ³ªÅ¸³»°Ô ÇÏ´Â ¾à. ±³°¨½Å°æÀÌ ÈïºÐÇßÀ» ¶§ ü³»¿¡´Â Ä«Å×ÄݾƹÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
chimpanzee coryza agent <virology> This RNA virus is a member of the Paramyxoviridae family and is a major pathogen in the upper and lower respiratory tract in both infants and younger children.
Respiratory syncytial virus manifestations include bronchiolitis, pneumonia and croup.
Acronym: RSV
(27 Sep 1997)
cholinergic agent An agent that mimics the action of the parasympathetic nervous system (e.g., methacholine).
(05 Mar 2000)
cholinergic parasympathomimetic agent <pharmacology> A chemical substance that causes the release of choline (acetylcholine) from parasympathetic nerve endings.
(15 Jan 1998)
Pittsburgh pneumonia agent A species that causes Pittsburgh pneumonia, a variant of Legionnaires' disease. Accounts for approximately 60% of Legionella pneumonias other than those caused by Legionella pneumophila.
Synonym: Pittsburgh pneumonia agent.
(05 Mar 2000)
contrast agent A substance that is introduced into or around a structure and, because of the difference in absorption of X-rays by the contrast medium and the surrounding tissues, allows radiographic visualisation of the structure.
(18 Nov 1997)
sclerosing agent A compound which acts by irritation of the veinous intimal epithelium; used in the treatment of varicose veins.
(05 Mar 2000)
high osmolar contrast agent Ionic water-soluble iodinated contrast media.
Synonym: high osmolar contrast medium.
(05 Mar 2000)
psychotropic agent A chemical compound that influences the human psyche.
(05 Mar 2000)
slow channel-blocking agent calcium channel-blocking agent
narcotic analgesic agent <pharmacology> Medications that relieve pain but have addictive potential if used regularly.
Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin.
(27 Sep 1997)
neuroleptic agent Any of a family of drugs producing sedation and tranquilization (e.g., chlorpromazine, haloperidol).
See: antipsychotic agent.
Synonym: neuroleptic.
(05 Mar 2000)
neuromuscular blocking agent A group of drugs that prevent motor nerve endings from exciting skeletal muscle. They act either by competing for the neurotransmitter, acetylcholine, (like D-tubocurarine, mivacurium and pancuronium), or by first stimulating the postjunctional muscle membrane and subsequently desensitizing the muscle endplates to the acetylcholine (like succinylcholine or decamethonium); used in surgery to produce paralysis and facilitate manipulation of muscles.
(05 Mar 2000)
nondepolarising neuromuscular blocking agent A compound that paralyzes skeletal muscle primarily by inhibiting transmission of nerve impulses at the neuromuscular junction rather than by affecting the membrane potention of motor endplate or muscle fibres.
(05 Mar 2000)
Norwalk agent A strain of epidemic gastroenteritis virus that appears to be related to the calciviruses.
Origin: Norwalk, Ohio, where first implicated in disease
(05 Mar 2000)
surface-active agent Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á